Manchester Capital Management’s Chemed CHE Stock Holding History

Manchester Capital Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.19K	Buy	+9	New	+$3.78K	﹤0.01%	914
2026 Q1	–	Sell	-6	Closed	-$2.57K	–	1327
2025 Q4	$2.57K	Buy	6 +2	+50%	+$871	﹤0.01%	976
2025 Q3	$1.79K	Buy	4 +3	+300%	+$1.36K	﹤0.01%	1095
2025 Q2	$487	Hold	1	–	–	﹤0.01%	1112
2025 Q1	$616	Hold	1	–	–	﹤0.01%	1075
2024 Q4	$530	Sell	1 -1	-50%	-$564	﹤0.01%	1077
2024 Q3	$1.2K	Hold	2	–	–	﹤0.01%	1023
2024 Q2	$1.09K	Buy	2 +1	+100%	+$573	﹤0.01%	1002
2024 Q1	$642	Hold	1	–	–	﹤0.01%	920
2023 Q4	$585	Hold	1	–	–	﹤0.01%	898
2023 Q3	$520	Hold	1	–	–	﹤0.01%	900
2023 Q2	$542	Hold	1	–	–	﹤0.01%	873
2023 Q1	$538	Hold	1	–	–	﹤0.01%	994
2022 Q4	$510	Buy	+1	New	+$487	﹤0.01%	906
2022 Q2	–	Sell	-3	Closed	-$2K	–	994
2022 Q1	$2K	Buy	+3	New	+$1.44K	﹤0.01%	801
2021 Q4	–	Sell	-6	Closed	-$3K	–	1020
2021 Q3	$3K	Sell	6 -8	-57%	-$3.77K	﹤0.01%	774
2021 Q2	$7K	Buy	+14	New	+$6.72K	﹤0.01%	526

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Manchester Capital Management's CHE Position: Q2 2026 in Review

Manchester Capital Management opened a new position in Chemed (CHE) in Q2 2026: 9 shares worth $4.19K. The stake represents ﹤0.01% of the portfolio and ranks #914 among its holdings. This is a return to the name: Manchester Capital Management previously reported a position in CHE as recently as Q4 2025.

Manchester Capital Management first reported a position in CHE in Q2 2021 and has held it in 17 quarters since. The position peaked at $7K in Q2 2021. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Manchester Capital Management held 9 shares of Chemed worth $4.19K as of Q2 2026.
Chemed was a new Manchester Capital Management position in Q2 2026.
Chemed made up ﹤0.01% of Manchester Capital Management's portfolio in Q2 2026, its #914 holding.
Manchester Capital Management first reported a position in Chemed in Q2 2021 and has held it in 17 quarters since.
Manchester Capital Management's Chemed position peaked at $7K in Q2 2021.
532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.